3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Lymphoma, Large B-Cell, Diffuse
19
Lymphoma
15
Burkitt Lymphoma
15
Neuroblastoma
12
Lymphoma, Non-Hodgkin
11
Recurrence
10
Lymphoma, Follicular
9
Leukemia
9
Lymphoma, T-Cell, Peripheral
6
Lymphoma, T-Cell
6
Lymphoma, B-Cell
6
Leukemia, Biphenotypic, Acute
6
Brain Neoplasms
6
Lymphoma, Mantle-Cell
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Central Nervous System Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Lymphoma, Large-Cell, Anaplastic
4
Lymphoma, B-Cell, Marginal Zone
4
Hodgkin Disease
4
HIV Infections
4
Acquired Immunodeficiency Syndrome
4
Sarcoma, Kaposi
3
Sarcoma, Ewing
3
Sarcoma
3
Medulloblastoma
3
Leukemia, Myeloid, Acute
3
Hematologic Neoplasms
3
Interventions
Rituximab
16
ibrutinib
9
Bortezomib
8
fludarabine phosphate
7
Lenalidomide
6
Cyclophosphamide
5
Bendamustine Hydrochloride
5
Peripheral Blood Stem Cell Transplantation
4
Flow Cytometry
4
Dasatinib
4
tanespimycin
3
pomalidomide
3
belinostat
3
Vorinostat
3
Polymerase Chain Reaction
3
Pharmacogenomic Testing
3
Melphalan
3
Everolimus
3
Etoposide
3
Dexamethasone
3
ublituximab
2
nelarabine
2
ibritumomab tiuxetan
2
fludarabine
2
carfilzomib
2
alvocidib
2
Tacrolimus
2
Methotrexate
2
Magnetic Resonance Spectroscopy
2
MLN 8237
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Waldenstrom Macroglobulinemia
×
Vincristine
×
Clear all
NCT02257242
2023-02-09
BRiM
Brown University
Phase 1
Completed
11 enrolled
20 charts